biotech investing

Amgen (NASDAQ:AMGN) today announced the presentation of new data across its rare disease portfolio and pipeline at…
Read More...

In a remarkable convergence of biology and artificial intelligence (AI), AlphaFold has emerged as a game-changer in…
Read More...

"This is the first approval for TEPEZZA in Asia and marks a significant milestone for the global treatment of…
Read More...

"This is the first approval for TEPEZZA in Asia and marks a significant milestone for the global treatment of…
Read More...

"The breadth of these data reflects our strategy to advance diverse modalities for difficult-to-treat cancers," said…
Read More...

"For the first time, children and adolescents with moderate to severe plaque psoriasis and their caregivers have an…
Read More...

Key results include: For the second quarter, total revenues increased 20% to $8.4 billion in comparison to the…
Read More...

Second quarter revenue was $10.54 billion. Second quarter GAAP diluted earnings per share (EPS) increased 15% to…
Read More...

At this year’s Collision event, held in Toronto from June 18 to 20, Wesley Chan, co-founder and managing partner at…
Read More...